Editorial Open Access
Copyright ©2010 Baishideng. All rights reserved
World J Gastroenterol. Feb 14, 2010; 16(6): 659-662
Published online Feb 14, 2010. doi: 10.3748/wjg.v16.i6.659
Is the DHEAS/cortisol ratio a potential filter for non-operable constipated cases?
AM El-Tawil
AM El-Tawil, Department of Surgery, East Corridor, Ground Floor, University Hospital of Birmingham, Edgbaston, Birmingham, B15 2TH, United Kingdom
Author contributions: El-Tawil AM wrote this paper.
Correspondence to: AM El-Tawil, MSc, MRCS, PhD, Department of Surgery, East Corridor, Ground Floor, University Hospital of Birmingham, Edgbaston, Birmingham, B15 2TH, United Kingdom. atawil20052003@yahoo.co.uk
Telephone: +44-121-6978231 Fax: +44-121-4466220
Received: October 12, 2009
Revised: November 12, 2009
Accepted: November 19, 2009
Published online: February 14, 2010

Abstract

Constipation is a significant manifestation of a number of psychological disorders. Published papers recommend using self-assessment questionnaires for discriminating psychological from non-psychological constipated patients before operating on them but reports from major surveys revealed that general practitioners failed to diagnose 70% of depressed patients using self-assessment questionnaires. Lower circulating concentrations of progesterone, 17-hydroxyprogesterone, cortisol, testosterone, androstenedione, and dehydroepiandrostenedione sulfate (DHEAS) during the follicular phase in constipated young women compared with respective controls were found during the follicular phase of the menstrual cycles. During the luteal phase of the cycle, reductions were identified in estriol, cortisol and testosterone in the constipated group. Likewise, circulating concentrations of DHEAS were found to be lower in depressed patients than comparable healthy controls. DHEAS/cortisol ratios in morning serum and salivary samples were lower than those retrieved during other times of the day in depressed patients. The idea of recognizing major depression in constipated patients by measuring DHEAS/cortisol ratios in saliva and serum may be plausible but this possibility needs to be confirmed in well-designed studies.

Key Words: Chronic constipation, Gastrointestinal motility, Colonic inertia, Steroid hormones, Adrenal hormones, Dehydroepiandrosterone, Depression, Anxiety



INTRODUCTION

Constipation is a prominent feature amongst patients with depression[1-5], anorexia nervosa, weight loss, sleep disorders[6], fatigue, and decreased sexual interest, particularly with menarche or after a stressful emotional experience[7,8] or surgical operation[9,10].

The outcome of treatment in patients with chronic constipation is unpredictable. This may be a consequence of the lack of effectiveness of such treatment or may reflect heterogeneity within patient subgroups.

IDIOPATHIC CHRONIC CONSTIPATION AND PSYCHOLOGICAL VARIABLES

A positive link was identified by Martelli et al[11] between various psychiatric variables and both outlet obstruction and colonic inertia. These results were further confirmed by others[12]. Fisher et al[13] conducted a survey in 50 patients, 21 of whom complained of chronic severe constipation, 29 had fecal incontinence, and none were receiving psychiatric therapy or had a history of a relevant medical condition or drug therapy that could lead to the development of any of these ailments. The participants were asked to complete the Hospital Anxiety & Depression Scale (HAD) questionnaire and the General Health Questionnaire (GHQ) before and after surgery to assess the surgical outcome. Constipated patients had significantly higher HAD depression scores in comparison with respective controls. Constipated patients who had improvement after surgery had significantly lower pre-operative HAD scores compared with those who had no improvement. Using the same parameters, incontinent patients did not differ from respective controls, but those who had bad results after surgery had significantly higher HAD scores than those who benefited from surgery.

Later on, a similar study was conducted where Ghosh et al[14] reported the HAD scores determined from a physician-administered questionnaire in patients with chronic constipation, ulcerative colitis, and cancer of the colon, and found a link between the score and the examined clinical symptoms, such as abdominal pain, straining at stool and urgency. The HAD scores were higher in the constipated group in comparison with others, and were significantly higher in those who complained of straining at stool.

However, use of a self-assessment questionnaire as a parameter in patients suffering from chronic disease could not be relied on without other evidence[15]. Published reports revealed that general practitioners could not diagnose a significant percentage of psychological cases using self-assessment questionnaires in patients with chronic diseases[16,17].

PHYSIOLOGY OF STEROIDS HORMONES AND MENSTRUAL CYCLE

Adrenal androgens represent an important component (> 50%) of the circulating androgens in menstruating females[18-25]. In males, the adrenal contribution is much less because of the testicular production of androgens. Adrenal secretion of androgens in men is about the same as in women during the follicular phase.

The adult adrenal gland secretes dehydroepiandrostenedione (DHEA) at approximately 4 mg/d, DHEA sulfate (DHEAS) at 7-15 mg/d, and androstenedione at 1.5 mg/d[26].

RELATIONSHIPS BETWEEN STEROID HORMONES AND BRAIN FUNCTIONS

The relationships between steroid hormones and brain functions have mostly been considered within the framework of endocrine mechanisms as genomic responses, elicited by secretory products from steroidogenic endocrine glands, transported through the bloodstream, and exerting actions on the brain. Ever since the biosynthesis of steroid hormones in the brain[27] and their rapid non-genomic actions[28,29] were first reported, specific targets for so-called “neurosteroids” in plasma membranes have been postulated.

DHEA and its metabolites, DHEAS and androsterone, have been identified recently as having neurosteroid activity.

DHEAS modulates the actions of the gamma-aminobutyric acid type A (GABAA) receptor, the N-methyl-D-aspartate receptor, and the sigma subtype 1 (r1) receptor[27,30-35] among others[36-38]. DHEA and DHEAS generally act as noncompetitive antagonists of the GABAA receptor. GABAA receptor-mediated regulation of 5-hydroxytryptamine (5-HT) neuronal firing was found to be sensitive to negative modulation by DHEA and DHEAS, and to positive modulation by androsterone. GABAA receptor-mediated regulation of 5-HT firing may be responsible for some of the reported behavioral and psychological effects of endogenous and exogenous DHEA[39]. An assessment of depression ratings in relation to plasma concentrations of several steroid hormones (estradiol, testosterone, estrone, androstenedione, cortisol, DHEA, and DHEAS) in 699 postmenopausal women (aged 50-90 years) who were not taking the contraceptive pill[40] found that only DHEAS concentrations were negatively correlated with ratings of depressed mood. Explicitly, higher DHEAS concentrations were associated with less depression, and this association was independent of age, physical activity and weight change. Furthermore, women with categorical diagnoses of depression had significantly lower plasma DHEAS concentrations compared to age-matched non-depressed women[41]. Similarly, in a large-scale study of 2855 well-functioning elderly men and women, serum DHEAS concentrations were inversely correlated with depressive symptoms[42]. Women whose first onset of major or minor depression occurred during the peri-menopause showed low morning plasma DHEA and DHEAS concentrations[43]. Lower plasma DHEA concentrations during pregnancy and during the postpartum period were associated with higher postpartum ratings of depression[44].

PATHOPHYSIOLOGY OF STEROID HORMONES IN SEVERELY CONSTIPATED PATIENTS

Levels of progesterone, 17-hydroxyprogesterone, cortisol, testosterone, androstenedione, and DHEAS were found to be lower during the follicular phase of the menstrual cycle in patients diagnosed with idiopathic chronic constipation compared with respective healthy controls[44].

A lack of estriol, cortisol and testosterone was identified during the luteal phase of the cycle in the constipated group[45]. The high prevalence of idiopathic constipation in pre-menopausal women is likely a result of the high affinity of progesterone for progesterone receptors together with the non-specific affinity for adrenal androgen receptors, and the lack of a stimulatory effect of estrogen on the wall of the bowel[45].

MEASUREMENT OF DHEAS/CORTISOL RATIO AND PSYCHOLOGICAL VARIABLES

A deficiency of DHEAS is thus identified in depression and constipation and it would be impossible to rely on it for distinguishing depressed, severely constipated patients. However, estimates of DHEA-to-cortisol ratios in serum and saliva, are likely to be more reliable than concentrations of either hormone alone, with lower morning ratios seen in depression[46-48]. The molar DHEAS/cortisol ratio was significantly lower in non-medicated depressed patients than in controls, and the evening salivary DHEA/cortisol ratio was inversely correlated with the length of the current depressive episode[49]. Morning salivary DHEA hyposecretion as well as evening cortisol hypersecretion were significantly and independently associated with major depression in young patients[49].

IMPLICATIONS IN RESEARCH AND IN CLINICAL PRACTICE

This review hypothesizes that measurement of the DHEAS/cortisol ratio in constipated patients could filter out those patients with a psychological disorder and improve the outcome after surgery.

For assessing the credibility of this measurement, a well-designed study needs to be conducted. The recruited constipated patients should have no personal or family background of a major psychological disorder. Participants should be asked to complete a stool diary.In this diary, they would be asked to report on the frequency, shape, consistency of stool, and whether they strained at defecation or not. The starting day would be their first menstruating day of the nearest menstruation cycle and the end would be the commencement of the next one. They would comment on the day and timing of defecation, stool consistency, stool form and the presence or absence of straining at stool.

They would also be asked to give 3 blood samples and 3 samples of saliva in any day during the mid-follicular period (days 7-10). The first samples would be collected early in the morning, the second on the afternoon and the third would be collected early in the evening.

Similarly, the same process would be repeated in any day during the mid-luteal period (days 18-20) to measure the DHEAS/cortisol ratio in serum and in saliva. The whole process would be repeated over the second consecutive menstrual cycle to obtain an average of each measurement. On these 2 d, participants would also be asked to fill in the Hospital Anxiety & Depression Scale questionnaire and General Health Questionnaire.

During the mid luteal period, the value of the DHEAS/cortisol ratio is supposed to be higher than that during the mid-follicular period in purely constipated patients. Because of ovarian secretions during the luteal phase, the concentration of DHEAS would be nearly normal but that of cortisol would still be low. However, in mixed cases, the ratio would be low, and in particular in the early morning samples.

CONCLUSION

The use of self-assessment questionnaires for excluding a psychological disorder in severely constipated patients seems insufficient, but the idea of measuring serum and salivary DHEAS/cortisol ratios before embarking upon invasive treatments appears to be more specific. This conclusion warrants confirmation in well-designed studies.

Footnotes

Peer reviewers: Akio Inui, MD, PhD, Professor, Department of Behavioral Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan; Steven D Wexner, MD, Professor of Surgery, The Cleveland Clinic Foundation Health Sciences Center of the Ohio State University, and Clinical Professor, Department of Surgery, Division of General Surgery, University of South Florida College of Medicine, 21st Century Oncology Chair in Colorectal Surgery, Chairman, Department of Colorectal Surgery, Chief of Staff, Cleveland Clinic Florida, 2950 Cleveland Clinic Boulevard, Weston, Florida, FL 33331, United States

S- Editor Tian L L- Editor Cant MR E- Editor Wang YR

References
1.  Donald IP, Smith RG, Cruikshank JG, Elton RA, Stoddart ME. A study of constipation in the elderly living at home. Gerontology. 1985;31:112-118.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Heymen S, Wexner SD, Gulledge AD. MMPI assessment of patients with functional bowel disorders. Dis Colon Rectum. 1993;36:593-596.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Sonnenberg A, Tsou VT, Müller AD. The "institutional colon": a frequent colonic dysmotility in psychiatric and neurologic disease. Am J Gastroenterol. 1994;89:62-66.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Chami TN, Andersen AE, Crowell MD, Schuster MM, Whitehead WE. Gastrointestinal symptoms in bulimia nervosa: effects of treatment. Am J Gastroenterol. 1995;90:88-92.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Meiring PJ, Joubert G. Constipation in elderly patients attending a polyclinic. S Afr Med J. 1998;88:888-890.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Caranasos G, Busby J. Sleep disorders, constipation, and pain: George Caranasos and Jan Busby. Interview by Richard L. Peck. Geriatrics. 1985;40:87-88, 90.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Devroede G, Girard G, Bouchoucha M, Roy T, Black R, Camerlain M, Pinard G, Schang JC, Arhan P. Idiopathic constipation by colonic dysfunction. Relationship with personality and anxiety. Dig Dis Sci. 1989;34:1428-1433.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Brook A. Bowel distress and emotional conflict. J R Soc Med. 1991;84:39-42.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Whitehead WE. Twin studies used to prove that the comorbidity of major depressive disorder with IBS is NOT influenced by heredity. Am J Gastroenterol. 2007;102:2230-2231.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Blandizzi C. Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders. Neurochem Int. 2007;51:282-288.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Martelli H, Devroede G, Arhan P, Duguay C. Mechanisms of idiopathic constipation: outlet obstruction. Gastroenterology. 1978;75:623-631.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol. 1997;32:1083-1089.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Fisher SE, Breckon K, Andrews HA, Keighley MR. Psychiatric screening for patients with faecal incontinence or chronic constipation referred for surgical treatment. Br J Surg. 1989;76:352-355.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Ghosh S, Papachrysostomou M, Batool M, Eastwood MA. Long-term results of subtotal colectomy and evidence of noncolonic involvement in patients with idiopathic slow-transit constipation. Scand J Gastroenterol. 1996;31:1083-1091.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  El-Tawal AM. Effects of five different drinks on patients with Crohn's disease. Scand J Gastroenterol. 2009;44:764.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Sireling LI, Paykel ES, Freeling P, Rao BM, Patel SP. Depression in general practice: case thresholds and diagnosis. Br J Psychiatry. 1985;147:113-119.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Sartorius N, Ustün TB, Lecrubier Y, Wittchen HU. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl. 1996;38-43.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab. 1986;15:213-228.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Fotherby K. Biosynthesis of oestrogen. Biochemistry of steroid hormones. Oxford: Blackwell Scientific 1984; 207-229.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Nelson DH The Adrenal Cortex: Physiological function and disease. Philadelphia: WB Saunders 1980; 1122.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab. 1974;39:340-346.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Orth DN, Kovacs WJ. The adrenal cortex. Williams textbook of Endocrinology. Philadelphia, Pa: WB Saunders 1998; 517-664.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Lachelin GC, Barnett M, Hopper BR, Brink G, Yen SS. Adrenal function in normal women and women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1979;49:892-898.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Rosenfeld RS, Rosenberg BJ, Fukushima DK, Hellman L. 24-Hour secretory pattern of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J Clin Endocrinol Metab. 1975;40:850-855.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Parker LN, Odell WD. Control of adrenal androgen secretion. Endocr Rev. 1980;1:392-410.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  McKenna TJ, Fearon U, Clarke D, Cunningham SK. A critical review of the origin and control of adrenal androgens. Baillieres Clin Obstet Gynaecol. 1997;11:229-248.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Compagnone NA, Mellon SH. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol. 2000;21:1-56.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Harrison NL, Simmonds MA. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 1984;323:287-292.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Maggi A, Perez J. Progesterone and estrogens in rat brain: modulation of GABA (gamma-aminobutyric acid) receptor activity. Eur J Pharmacol. 1984;103:165-168.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res. 1997;52:1-32.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Baulieu EE. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology. 1998;23:963-987.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Bergeron R, de Montigny C, Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci. 1996;16:1193-1202.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol. 1992;38:379-395.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Maurice T, Grégoire C, Espallergues J. Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav. 2006;84:581-597.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab. 2002;13:35-43.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Pérez-Neri I, Montes S, Ojeda-López C, Ramírez-Bermúdez J, Ríos C. Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1118-1130.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology. 2003;28:139-168.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Rupprecht R, di Michele F, Hermann B, Ströhle A, Lancel M, Romeo E, Holsboer F. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev. 2001;37:59-67.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Gartside S, Griffith N, Kaura V, Ingram C. The neurosteroid dehydroepiandrosterone (DHEA) and its metabolites alter 5-HT neuronal activity via modulation of GABAA receptors. J Psychopharmacol. 2009;Epub ahead of print.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Barrett-Connor E, von Mühlen D, Laughlin GA, Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc. 1999;47:685-691.  [PubMed]  [DOI]  [Cited in This Article: ]
41.  Morsink LF, Vogelzangs N, Nicklas BJ, Beekman AT, Satterfield S, Rubin SM, Yaffe K, Simonsick E, Newman AB, Kritchevsky SB. Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: results from the Health ABC study. Psychoneuroendocrinology. 2007;32:874-883.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Schmidt PJ, Murphy JH, Haq N, Danaceau MA, St Clair L. Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology. 2002;27:907-920.  [PubMed]  [DOI]  [Cited in This Article: ]
43.  Buckwalter JG, Stanczyk FZ, McCleary CA, Bluestein BW, Buckwalter DK, Rankin KP, Chang L, Goodwin TM. Pregnancy, the postpartum, and steroid hormones: effects on cognition and mood. Psychoneuroendocrinology. 1999;24:69-84.  [PubMed]  [DOI]  [Cited in This Article: ]
44.  Kamm MA, Farthing MJ, Lennard-Jones JE, Perry LA, Chard T. Steroid hormone abnormalities in women with severe idiopathic constipation. Gut. 1991;32:80-84.  [PubMed]  [DOI]  [Cited in This Article: ]
45.  Assies J, Visser I, Nicolson NA, Eggelte TA, Wekking EM, Huyser J, Lieverse R, Schene AH. Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings. Psychiatry Res. 2004;128:117-122.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Michael A, Jenaway A, Paykel ES, Herbert J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry. 2000;48:989-995.  [PubMed]  [DOI]  [Cited in This Article: ]
47.  Osran H, Reist C, Chen CC, Lifrak ET, Chicz-DeMet A, Parker LN. Adrenal androgens and cortisol in major depression. Am J Psychiatry. 1993;150:806-809.  [PubMed]  [DOI]  [Cited in This Article: ]
48.  Young AH, Gallagher P, Porter RJ. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am J Psychiatry. 2002;159:1237-1239.  [PubMed]  [DOI]  [Cited in This Article: ]
49.  Goodyer IM, Herbert J, Altham PM, Pearson J, Secher SM, Shiers HM. Adrenal secretion during major depression in 8- to 16-year-olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol Med. 1996;26:245-256.  [PubMed]  [DOI]  [Cited in This Article: ]